Prestige Takes Trastuzumab A Step Closer To US Filing

As Major Shareholder Invests Further In Singapore-Based Biosimilars Developer

 
• By David Wallace
  
Blue Steps Final Light
Prestige’s meeting with the FDA is the final step before filing • Source: Shutterstock

More from Biosimilars

More from Products